期刊文献+
共找到12篇文章
< 1 >
每页显示 20 50 100
Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment 被引量:12
1
作者 Yuting Zhang Guoqiang Liu +1 位作者 Miaomiao Sun Xin Lu 《Cancer Biology & Medicine》 SCIE CAS CSCD 2020年第1期32-43,共12页
Neutrophils,the most abundant leukocytes in human blood,are essential fighter immune cells against microbial infection.Based on the finding that neutrophils can either restrict or promote cancer progression,tumor-asso... Neutrophils,the most abundant leukocytes in human blood,are essential fighter immune cells against microbial infection.Based on the finding that neutrophils can either restrict or promote cancer progression,tumor-associated neutrophils(TAN)are classified into anti-tumor N1 and pro-tumor N2 subsets.One of the major mechanisms underlying the tumor-promoting function of N2-TANs is suppression of adaptive immune cells,in particular,cytotoxic T lymphocytes.Currently,no established methodologies are available that can unequivocally distinguish immunosuppressive TANs and granulocytic/polymorphonuclear myeloid-derived suppressor cells(G/PMN-MDSC).In view of the critical role of PMN-MDSCs in immune evasion and resistance to cancer immunotherapy,as established from data obtained with diverse cancer models,therapeutic strategies targeting these cells have been actively developed to enhance the efficacy of immunotherapy.Here,we have reviewed the available literature on strategies targeting PMN-MDSCs and summarized the findings into four categories:(1)depletion of existing PMN-MDSCs,(2)blockade of the development of PMNMDSCs,(3)blockade of PMN-MDSC recruitment,(4)inhibition of immunosuppressive function.Owing to their high mobility to inflamed organs and ability to trespass the blood-brain barrier,neutrophils are outstanding candidate carriers in nanoparticle-based therapies.Another attractive application of neutrophils in cancer therapy is the use of neutrophil membrane-derived nanovesicles as a surrogate of extracellular vesicles for more efficient and scalable drug delivery.In the second part of the review,we have highlighted recent advances in the field of neutrophil-based cancer drug delivery.Overall,we believe that neutrophil-based therapeutics are a rapidly growing area of cancer therapy with significant potential benefits. 展开更多
关键词 tumor-associated neutrophil polymorphonuclear myeloid-derived suppressor cell IMMUNOSUPPRESSION cancer immunotherapy nanoparticle drug delivery
下载PDF
Heterogeneity of neutrophils in cancer:one size does not fit all 被引量:1
2
作者 Song Chen Qingyu Zhang +6 位作者 Lisha Lu Chunhui Xu Jiajia Li Jiali Zha Fengxia Ma Hongbo R.Luo Alan Y.Hsu 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第12期1629-1648,共20页
Neutrophils play an essential role in the defense against bacterial infections and orchestrate both the innate and adaptive immune responses.With their abundant numbers,diverse function and short life span,these cells... Neutrophils play an essential role in the defense against bacterial infections and orchestrate both the innate and adaptive immune responses.With their abundant numbers,diverse function and short life span,these cells are at the forefront of immune responses,and have gained attention in recent years because of their presence in tumor sites.Neutrophil involvement pertains to tumor cells'ability to construct a suitable tumor microenvironment(TME)that accelerates their own growth and malignancy,by facilitating their interaction with surrounding cells through the circulatory and lymphatic systems,thereby influencing tumor development and progression.Studies have indicated both pro-and anti-tumor properties of infiltrating neutrophils.The TME can exploit neutrophil function,recruitment,and even production,thus resulting in pro-tumor properties of neutrophils,including promotion of genetic instability,tumor cell proliferation,angiogenesis and suppression of anti-tumor or inflammatory response.In contrast,neutrophils can mediate anti-tumor resistance by direct cytotoxicity to the tumor cells or by facilitating anti-tumor functions via crosstalk with T cells.Here,we summarize current knowledge regarding the effects of neutrophil heterogeneity under homeostatic and tumor conditions,including neutrophil phenotype and function,in cancer biology. 展开更多
关键词 neutrophils in cancer tumor microenvironment tan neutrophil heterogeneity neutrophils
下载PDF
Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis 被引量:2
3
作者 Yau-tuen Chan Hor-yue Tan +5 位作者 Yuanjun Lu Cheng Zhang Chien-shan Cheng Junyu Wu Ning Wang Yibin Feng 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第4期1554-1567,共14页
Tumor microenvironment contributes to poor prognosis of pancreatic adenocarcinoma(PAAD)patients.Proper regulation could improve survival.Melatonin is an endogenous hormone that delivers multiple bioactivities.Here we ... Tumor microenvironment contributes to poor prognosis of pancreatic adenocarcinoma(PAAD)patients.Proper regulation could improve survival.Melatonin is an endogenous hormone that delivers multiple bioactivities.Here we showed that pancreatic melatonin level is associated with patients'survival.In PAAD mice models,melatonin supplementation suppressed tumor growth,while blockade of melatonin pathway exacerbated tumor progression.This anti-tumor effect was independent of cytotoxicity but associated with tumor-associated neutrophils(TANs),and TANs depletion reversed effects of melatonin.Melatonin induced TANs infiltration and activation,therefore induced cell apoptosis of PAAD cells.Cytokine arrays revealed that melatonin had minimal impact on neutrophils but induced secretion of Cxcl2 from tumor cells.Knockdown of Cxcl2 in tumor cells abolished neutrophil migration and activation.Melatonin-induced neutrophils presented an N1-like anti-tumor phenotype,with increased neutrophil extracellular traps(NETs)causing tumor cell apoptosis through cell-to-cell contact.Proteomics analysis revealed that this reactive oxygen species(ROS)-mediated inhibition was fueled by fatty acid oxidation(FAO)in neutrophils,while FAO inhibitor abolished the anti-tumor effect.Analysis of PAAD patient specimens revealed that CXCL2 expression was associated with neutrophil infiltration.CXCL2,or TANs,combined with NET marker,can better predict patients'prognosis.Collectively,we discovered an anti-tumor mechanism of melatonin through recruiting N1-neutrophils and beneficial NET formation. 展开更多
关键词 Pancreatic adenocarcinoma MELATONIN Anti-tumor immunity tumor-associated neutrophils Tumor microenvironment CXCL2 neutrophil extracellular traps NETosis
原文传递
The Role of Neutrophils in Cancer Development
4
作者 Fei Fei Guo Jiu Wei Cui 《Journal of Nutritional Oncology》 2019年第2期85-90,共6页
In recent years, the numerous roles of neutrophils have gained increasing attention. Beyond their traditional role in infection control, research on neutrophils has expanded to their roles in tumor regulation. It has ... In recent years, the numerous roles of neutrophils have gained increasing attention. Beyond their traditional role in infection control, research on neutrophils has expanded to their roles in tumor regulation. It has been found that neutrophils present in the tumor microenvironment, tumor-associated neutrophils (TANs), exert complex and apparently opposing effects by reducing and promoting tumor growth and progression in response to various factors in the tumor microenvironment. In addition, recent studies have reported the heterogeneity and complex tumor regulation of circulating neutrophils. The present paper provides a summary of the related research progress. 展开更多
关键词 TUMOR MICROENVIRONMENT CIRCULATING neutrophils tumor-associated neutrophils CANCER therapy
下载PDF
肿瘤相关中性粒细胞的异质性及潜在的临床意义
5
作者 张铎 路丽明 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2024年第4期319-325,共7页
恶性肿瘤组织中肿瘤相关中性粒细胞(TAN)是肿瘤微环境的重要组成部分。TAN在肿瘤中的作用具有两面性。一方面,TAN可直接杀伤肿瘤细胞,或介导其他免疫细胞协同抗肿瘤。另一方面,TAN也可促进肿瘤血管生成、重塑细胞外基质及参与肿瘤细胞... 恶性肿瘤组织中肿瘤相关中性粒细胞(TAN)是肿瘤微环境的重要组成部分。TAN在肿瘤中的作用具有两面性。一方面,TAN可直接杀伤肿瘤细胞,或介导其他免疫细胞协同抗肿瘤。另一方面,TAN也可促进肿瘤血管生成、重塑细胞外基质及参与肿瘤细胞免疫逃逸。以上TAN功能的异质性是其在肿瘤微环境中多种复杂机制的交互调控下形成的,对肿瘤的发展或抑制产生重要的作用。因此,阐明TAN的异质性、不同亚群转化机制及其潜在的临床意义显得尤为重要,不仅有助于开发针对促肿瘤型中性粒细胞亚群的抑制类药物和疗法,还可进一步促进免疫治疗更多获益人群的新评估标准建立和筛选。 展开更多
关键词 肿瘤 肿瘤相关中性粒细胞 中性粒细胞异质性 免疫治疗 免疫抑制
下载PDF
肿瘤相关中性粒细胞的研究进展 被引量:5
6
作者 秦琪 徐洋 +1 位作者 赵红 张清媛 《实用肿瘤学杂志》 CAS 2017年第4期367-370,共4页
肿瘤生长依赖肿瘤微环境,肿瘤相关中性粒细胞(TANs)是肿瘤微环境中的一种重要炎症细胞。TANs分为具有抗肿瘤效应的"N1"型和促肿瘤效应的"N2"型。因此,TANs具有对机体有利和有害的两面性。大量研究表明,TANs通过分... 肿瘤生长依赖肿瘤微环境,肿瘤相关中性粒细胞(TANs)是肿瘤微环境中的一种重要炎症细胞。TANs分为具有抗肿瘤效应的"N1"型和促肿瘤效应的"N2"型。因此,TANs具有对机体有利和有害的两面性。大量研究表明,TANs通过分泌细胞因子和化学因子等,影响肿瘤的生成、转移、血管生成与免疫调节。本文将从TANs的生物学特性和TANs与肿瘤发生发展、预后及治疗等方面,综述TANs和肿瘤关系的研究进展。 展开更多
关键词 肿瘤相关中性粒细胞 肿瘤微环境 肿瘤
下载PDF
肿瘤相关中性粒细胞对肿瘤生长的双重作用 被引量:5
7
作者 刘天聪 王欢 吕昌龙 《微生物学免疫学进展》 2013年第2期61-64,共4页
肿瘤微环境中存在的肿瘤相关中性粒细胞具有促进和抑制肿瘤形成的双重作用,其中"N2"型TANs可以通过释放弹性蛋白酶、基质金属蛋白酶、细胞因子和趋化因子等方式,促进肿瘤增殖、转移和肿瘤血管的生成;"N1"型TANs可... 肿瘤微环境中存在的肿瘤相关中性粒细胞具有促进和抑制肿瘤形成的双重作用,其中"N2"型TANs可以通过释放弹性蛋白酶、基质金属蛋白酶、细胞因子和趋化因子等方式,促进肿瘤增殖、转移和肿瘤血管的生成;"N1"型TANs可抑杀肿瘤细胞发挥抗肿瘤作用。以TANs及其分泌的细胞因子为靶点,调控"N2"和"N1"型TANs介导产生的促肿瘤和抗肿瘤功能,可能成为肿瘤免疫治疗的一种有效策略。 展开更多
关键词 肿瘤相关中性粒细胞 免疫治疗 粒细胞弹性蛋白酶 基质金属蛋白酶
下载PDF
肿瘤相关中性粒细胞与肿瘤的发生和发展 被引量:7
8
作者 王青青 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2010年第5期487-491,共5页
肿瘤微环境中除了肿瘤细胞外,还存在多种类型的其他细胞,包括基质细胞、内皮细胞和各种免疫细胞(如CD4+和CD8+T细胞、树突状细胞、NK细胞、巨噬细胞、中性粒细胞等)。近年来研究发现,肿瘤相关中性粒细胞(tumor-assoc iated neutroph ils... 肿瘤微环境中除了肿瘤细胞外,还存在多种类型的其他细胞,包括基质细胞、内皮细胞和各种免疫细胞(如CD4+和CD8+T细胞、树突状细胞、NK细胞、巨噬细胞、中性粒细胞等)。近年来研究发现,肿瘤相关中性粒细胞(tumor-assoc iated neutroph ils,TANs)在肿瘤发生和发展中发挥着重要的作用。TANs可以通过多种机制促进肿瘤的生长和转移,这些机制包括TANs释放的弹性蛋白酶促进肿瘤增殖和转移,TANs分泌基质金属蛋白酶促进肿瘤血管的生成,同时高度活化的TANs也可杀伤肿瘤细胞起抗肿瘤的作用。对TANs的深入研究为肿瘤免疫提供了新的认识,以TANs及其分泌的一些分子作为靶点来调控TANs的功能,可能成为干预肿瘤发生、发展的重要方法。 展开更多
关键词 肿瘤相关中性粒细胞 肿瘤 粒细胞弹性蛋白酶 基质金属蛋白酶
下载PDF
中性粒细胞的免疫抑制亚群及功能和机制研究进展 被引量:11
9
作者 汤成婕 疏龙强 +4 位作者 吴缘开 赵良娟 张亦凡 侯亚菲 路丽明 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2020年第9期833-842,共10页
中性粒细胞是健康成人外周血中数量最多的白细胞,是抗感染的第一道防线。具有免疫抑制性作用的中性粒细胞亚群包括如肿瘤相关中性粒细胞(TAN)、低密度中性粒细胞(LDN)。这些中性粒细胞亚群通过程序性死亡蛋白1及其配体1(PD-1/PD-L1)、... 中性粒细胞是健康成人外周血中数量最多的白细胞,是抗感染的第一道防线。具有免疫抑制性作用的中性粒细胞亚群包括如肿瘤相关中性粒细胞(TAN)、低密度中性粒细胞(LDN)。这些中性粒细胞亚群通过程序性死亡蛋白1及其配体1(PD-1/PD-L1)、抗原提呈、活性氧(ROS)、精氨酸酶1(Arg1)、诱导型一氧化氮合酶(iNOS)等途径,调节T细胞免疫功能、促进血管生成和肿瘤生长,参与多种生理和病理过程,产生了许多新兴的治疗靶点和预后指标。 展开更多
关键词 中性粒细胞 肿瘤相关中性粒细胞(tan) 低密度中性粒细胞(LDN) 免疫抑制 髓源性抑制细胞(MDSC) 综述
下载PDF
EBV阳性鼻咽癌相关性中性粒细胞抑制肿瘤微环境中的CD8^(+)T细胞活化 被引量:3
10
作者 欧阳蒂君 陈楠 +3 位作者 杨洁莹 陈媛媛 向橦 夏建川 《中国肿瘤生物治疗杂志》 CAS CSCD 北大核心 2022年第5期399-409,共11页
目的:分析鼻咽癌(NPC)肿瘤微环境(TME)中的肿瘤相关中性粒细胞(TAN)浸润与患者的预后和临床病理特征之间的相关性,初步探讨EBV阳性NPC的TAN对CD8^(+)T细胞活化的作用。方法:收集2008年至2012年间中山大学肿瘤防治中心收治的118例初治且... 目的:分析鼻咽癌(NPC)肿瘤微环境(TME)中的肿瘤相关中性粒细胞(TAN)浸润与患者的预后和临床病理特征之间的相关性,初步探讨EBV阳性NPC的TAN对CD8^(+)T细胞活化的作用。方法:收集2008年至2012年间中山大学肿瘤防治中心收治的118例初治且无转移的EBV阳性NPC患者的肿瘤组织标本,通过免疫组织化学染色法观察并分析NPC组织中CD8^(+)T细胞、TAN浸润和EBV感染之间的关系,检测NPC组织标本中的TAN浸润程度并分析其与患者预后和临床病理特征之间的关系;流式细胞术检测HK1-EBV细胞培养上清液对TAN极化的N2型标志物(CD182和CD206)表达水平的影响,并进一步检测极化后的TAN对CD8^(+)T细胞活化标志物(CD69和PD-1)表达水平的影响。结果:EBV阳性NPC组织中CD8^(+)T细胞和TAN浸润增多且两者在数量上呈负相关关系(P=0.005 2);EBV阳性NPC组织中高水平浸润的TAN与患者的不良预后密切相关(OS:P=0.025,PFS:P=0.027),TAN浸润水平是EBV阳性NPC患者总生存时间(P=0.035)的独立预后因子;与对照组相比,HK1-EBV细胞培养上清液可诱导TAN极化并高表达N2型标志物(CD182:P<0.001;CD206:P<0.01);极化后的TAN可抑制CD8^(+)T细胞CD69的表达并促进PD-1的表达(P<0.001)。结论:EBV阳性NPC能够促进TME中的TAN浸润增多并使其极化成N2型,从而抑制CD8+T细胞的活化,发挥免疫抑制作用,与NPC患者的不良预后密切相关。 展开更多
关键词 EB病毒 鼻咽癌 肿瘤相关中性粒细胞 CD8^(+)T细胞 肿瘤微环境
下载PDF
肿瘤相关性中性粒细胞促肿瘤转移机制的研究进展 被引量:6
11
作者 李佳庆 王清莹 程忠平 《中国肿瘤临床》 CAS CSCD 北大核心 2019年第10期524-527,共4页
中性粒细胞是循环中最为丰富的白细胞,在机体的免疫反应中发挥重要作用。中性粒细胞不仅参与免疫反应,也在肿瘤的发生发展,特别是侵袭和转移过程中发挥重要作用。中性粒细胞可分化为N1和N2亚型,在肿瘤的转移中表现出抑制转移(N1)和促进... 中性粒细胞是循环中最为丰富的白细胞,在机体的免疫反应中发挥重要作用。中性粒细胞不仅参与免疫反应,也在肿瘤的发生发展,特别是侵袭和转移过程中发挥重要作用。中性粒细胞可分化为N1和N2亚型,在肿瘤的转移中表现出抑制转移(N1)和促进转移(N2)两种截然不同的的作用。但肿瘤相关中性粒细胞(tumor-associated neutrophils,TANs)在肿瘤转移机制中发挥的作用相对比较复杂,尚缺乏系统阐述。本文主要介绍TANs,分析其在肿瘤转移过程中促进肿瘤发生侵袭和转移的机制,对TANs作为抗肿瘤治疗策略的可能性进行综述。 展开更多
关键词 肿瘤相关中性粒细胞 肿瘤 转移 机制
下载PDF
Role of myeloid cells in the tumor microenvironment
12
作者 Arpita Balakrishnan Mohini Vig Shweta Dubey 《Journal of Cancer Metastasis and Treatment》 2022年第1期317-333,共17页
The dynamic interplay between tumor cells and immune cells in the microenvironment plays a crucial role in determining disease severity and therapeutic outcome in cancer.Myeloid cells are the most abundantly available... The dynamic interplay between tumor cells and immune cells in the microenvironment plays a crucial role in determining disease severity and therapeutic outcome in cancer.Myeloid cells are the most abundantly available cell population in the tumor microenvironment.Myeloid cells have been shown to exist in diverse phenotypes and play both antitumoral and protumoral roles in cancer.Understanding the biology of myeloid cells can lay the foundation for the development of therapeutic strategies aimed at enhancing the antitumoral role of myeloid cells.This article presents an overview of the role of myeloid cells in tumor development and various mechanisms by which myeloid cells aid tumor progression.Existing drugs against cancer that utilize myeloid cells and the role of myeloid cells in drug resistance are also discussed. 展开更多
关键词 Myeloid cells TUMOR CANCER tumor microenvironment tumor-associated macrophages dendritic cells tumor-associated neutrophils myeloid-derived suppressor cells
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部